Bridgeway Capital Management, LLC Werewolf Therapeutics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $3.75 Billion
- Q1 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 39,586 shares of HOWL stock, worth $48,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,586
Previous 109,586
63.88%
Holding current value
$48,690
Previous $162,000
76.54%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HOWL
# of Institutions
71Shares Held
27.3MCall Options Held
300Put Options Held
13.6K-
Ra Capital Management, L.P. Boston, MA6.14MShares$7.56 Million0.12% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.3 Million6.02% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.08 Million0.19% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.96 Million0.43% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$2.59 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $36.3M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...